Mazor Robotics Gains China Approval for Surgical Guidance System

Israel's Mazor Robotics received CFDA approval to market its Renaissance® guidance system in China. Renaissance is a guidance system for spine surgeries. The system will be marketed in China by Cicel, a medical device distribution company that is based in Beijing. Cicel believes that several hundred China hospitals are viable candidates for the system. More details.... Stock Symbols: (TASE: MZOR; NSDQ: MZOR) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.